162 related articles for article (PubMed ID: 4053275)
1. Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat.
Gottfried-Anacker J; Preussmann R; Eisenbrand G; Janzowski C
Carcinogenesis; 1985 Nov; 6(11):1559-64. PubMed ID: 4053275
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluorination on in-vitro metabolism and biological activity of N-nitrosodialkylamines.
Janzowski C; Eisenbrand G; Gottfried J; Preussmann R
IARC Sci Publ; 1984; (57):553-8. PubMed ID: 6533047
[TBL] [Abstract][Full Text] [Related]
3. Fluoro-substituted N-nitrosamines. 7. Non-genotoxic N-nitroso-bis(2,2,2-trifluoroethyl)amine and N-nitroso-bis(2,2,3,3,4,4,4-heptafluorobutyl)amine: binding to cytochrome P-450, acidity of alpha-protons and pharmacokinetic investigations.
Janzowski C; Gottfried J; Preussmann R; Eisenbrand G
Carcinogenesis; 1985 Jan; 6(1):79-84. PubMed ID: 2981643
[TBL] [Abstract][Full Text] [Related]
4. Fluoro-substituted N-nitrosamines. 3. Microsomal metabolism of N-nitrosodibutylamine and of fluorinated analogs.
Janzowski C; Gottfried J; Eisenbrand G; Preussman R
Carcinogenesis; 1982; 3(7):777-80. PubMed ID: 7116573
[TBL] [Abstract][Full Text] [Related]
5. Investigations on organ-specific metabolism and genotoxic effects of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine (BCPN) and its analogs N-nitrosodibutylamine (NDBA) and N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA).
Janzowski C; Jacob D; Henn I; Zankl H; Poole-Zobel BL; Eisenbrand G
Toxicology; 1989 Dec; 59(2):195-209. PubMed ID: 2588266
[TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of omega-1 and omega-2 oxidized N-nitrosodibutylamines in the rat.
Suzuki E; Okada M
Jpn J Cancer Res; 1985 Mar; 76(3):173-83. PubMed ID: 3922835
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of N,N-dibutylnitrosamine in the rat.
Suzuki E; Okada M
Gan; 1980 Dec; 71(6):863-70. PubMed ID: 7274631
[TBL] [Abstract][Full Text] [Related]
8. Fluoro-substituted N-nitrosamines. 5. Carcinogenicity of n-nitroso-bis-(4,4,4-trifluoro-n-butyl)amine in rats.
Preussmann R; Habs M; Habs H; Stummeyer D
Carcinogenesis; 1982; 3(10):1219-22. PubMed ID: 7172421
[TBL] [Abstract][Full Text] [Related]
9. In-vitro metabolism of fluorinated diakylnitrosamines.
Janzowski C; Gottfried J; Pool BL; Eisenbrand G; Preussmann R
IARC Sci Publ; 1982; (41):517-24. PubMed ID: 7141558
[TBL] [Abstract][Full Text] [Related]
10. Intestinal first-pass metabolism of nitrosamines. 2. Metabolism of N-nitrosodibutylamine in isolated perfused rat small intestinal segments.
Richter E; Zwickenpflug W; Wiessler M
Carcinogenesis; 1988 Mar; 9(3):499-506. PubMed ID: 3345589
[TBL] [Abstract][Full Text] [Related]
11. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
Suzuki E; Anjo T; Aoki J; Okada M
Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites].
Morishita S; Hamami G; Kamidono S
Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
[TBL] [Abstract][Full Text] [Related]
14. Influence of disulfiram on the metabolism of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
Irving CC; Daniel DS
Carcinogenesis; 1987 Sep; 8(9):1309-15. PubMed ID: 3113755
[TBL] [Abstract][Full Text] [Related]
15. Experimental model for evaluating animal exposure to endogenous N-nitrosodi-n-butylamine by measuring its urinary metabolites N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-butyl-N-(3-carboxypropyl)nitrosamine.
Airoldi L; Spagone C; Macri A; Fanelli R
IARC Sci Publ; 1984; (57):237-40. PubMed ID: 6533013
[TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
Suzuki E; Okada M
Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
[TBL] [Abstract][Full Text] [Related]
17. [Structure and metabolic fate of N-nitrosodialkylamines in relation to their organotropic carcinogenicity with special reference to induction of urinary bladder tumors].
Mochizuki M; Suzuki E; Okada M
Yakugaku Zasshi; 1997 Nov; 117(10-11):884-94. PubMed ID: 9414598
[TBL] [Abstract][Full Text] [Related]
18. Intestinal first-pass metabolism of nitrosamines. 4. Metabolism of N-nitrosodibutylamine in vascularly autoperfused jejunal and ileal loops of rats.
Richter E; Feng XC; Wiessler M
Carcinogenesis; 1990 Sep; 11(9):1517-21. PubMed ID: 2205408
[TBL] [Abstract][Full Text] [Related]
19. Fluoro-substituted N-nitrosamines. 4. Comparative genotoxic activities of N-nitrosodibutylamine and three fluorinated analogues in two bacterial systems.
Pool BL; Janzowski C; Eisenbrand G; Preussmann R
Carcinogenesis; 1982; 3(7):781-4. PubMed ID: 6749319
[TBL] [Abstract][Full Text] [Related]
20. Hydroxylation of dibutylnitrosamine in the human liver and intestinal microsomal fractions.
Pacifici GM; Richter E; Lehmann G; Wiessler M; Zwickenpflug W; Giuliani L
Arch Toxicol; 1986 Feb; 58(3):196-8. PubMed ID: 3964084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
